GlyCardial Diagnostics is a Barcelona, Spain-based biotechnology spin-off of the Catalan Institute of Cardiovascular Sciences. The company has developed a biomarker intended to detect a possible ischaemic attack before it happens and to identify patients at risk of a repeat cardiovascular event. Its core product is a new blood test to diagnose cardiac ischaemia in the early stages. GlyCardial intends to complete clinical validation and obtain CE marking for the test over the next three years. The company was created this year by scientists Lina Badimon, Judit Cubedo, Teresa Padró and Gemma Vilahur. It recently raised €2.4M to advance development of its first test.

Total raised

$3M

Funding rounds

1

Latest round

Equity

Latest activity

Nov 2017